Dr Jane Oppenheim
Dr Jane Oppenheim is the scientific and operations director of Ego Pharmaceuticals, where she leads a team of 280 in a continually expanding facility.
For more than three decades, she’s led the development of dermatological products at Ego, with five product ranges now the market leaders in Australia, including head lice, sun protection and therapeutic skin care. She has run, and now takes an active interest in, the multiple clinical and efficacy studies to support the therapeutic claims of Ego’s products.
She’s led the marketing authorisation and managing compliance with pharmaceutical regulations in more than 20 countries, including the UK, Middle East and Asia, and continues to lead the quality assurance team.
Enthusiastic about sustainability, she oversees projects to ensure Ego Pharmaceuticals has a positive impact on the environment in which it operates. Current programs include the minimisation of both water and energy usage.
She has a Bachelor of Science with honours in biochemistry and a PhD from Monash. Following her PhD, she took up a postdoctoral fellowship in immunoparasitology at the Walter and Eliza Hall Institute of Medical Research, where she was involved in researching candidate molecules for a malaria vaccine. The advisory boards on which she’s served include Monash’s School of Chemistry.